BEAM earnings: a negative outcome, -6.7%

On May 9, 2022, Beam Therapeutics Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.7% in the window around the event. It had already run -31.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.